At the news
? NEUTRALIMPACT 2/10 144 filed Nov 12, 2026 at 16:17 ET
Richard R. DeLuca Jr., an officer of Merck, filed a Form 144 notice of intent to sell 58,185 shares of common stock, with an approximate market value of $8.6 million based on the filing date. The shares were acquired through exercise of options under a registered plan. The sale is a routine insider transaction and represents a small fraction of Merck's market cap.
- Richard R. DeLuca Jr., an officer of Merck, filed Form 144 on 2026-11-12
- Proposed sale of 58,185 shares of common stock
- Estimated aggregate market value of $8,611,874.57
- Shares acquired via exercise of options under a registered plan on 2026-11-12
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access